2. Academic Validation
  3. The Oral PCSK9 inhibitor enlicitide for hypercholesterolemia

The Oral PCSK9 inhibitor enlicitide for hypercholesterolemia

  • Eur J Intern Med. 2026 Mar 14:106835. doi: 10.1016/j.ejim.2026.106835.
Mohammed A Elbahloul 1,  Aliaa Gamal 2,  Islam Y Elgendy 3
Affiliations

Affiliations

  • 1 Faculty of Medicine, Kafr El-Shaikh University, Kafr El Shaikh, Egypt. Electronic address: drmohammedelbahloul@gmail.com.
  • 2 Clinical Pharmacy Department, Faculty of Pharmacy, Deraya University, Minia, Egypt.
  • 3 Division of Cardiovascular Medicine, Gill Heart and Vascular Institute, University of Kentucky, Lexington, USA.
PMID: 41833476 DOI: 10.1016/j.ejim.2026.106835
Keywords

Enlicitide; Hypercholesterolemia; Oral PCSK9 Inhibitor; meta-analysis.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z